Key points are not available for this paper at this time.
The real incidence of triple negative breast cancer (TNBC) in India has always been a topic of debate. There has been considerable heterogeneity in the reporting of TNBC rates in India. A recent meta-analysis of 34 studies done till 2019 that included 20,678 patients reported a pooled prevalence of 27% (95% confidence interval CI: 24–31%).1 Our previous work in which we collected data from 17 studies done between 1999 and 2015 involving 7,237 patients from all four regions of India reported a TNBC rate of 31% (95% CI: 27–35%).2
Roy et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: